We are live on ! Find out more
CPV

Canaan Partners VII Portfolio holdings

AUM $32.3M
1-Year Est. Return 154.97%
This Fund
S&P 500
This Quarter Est. Return
-43.01%
1 Year Est. Return
+154.97%
3 Year Est. Return
-20.69%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$129M
AUM Growth
-$114M
Cap. Flow
-$460K
Cap. Flow %
-0.36%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TLRA
Telaria, Inc.
TLRA
+$265K
2
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
+$195K

Sector Composition

Rank Sector Weight
1 Financials 86.45%
2 Communication Services 11.13%
3 Healthcare 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HAPN
1
Happen Inc
HAPN
$2.07B
$112M 86.45%
5,186,735
– –
TLRA
2
DELISTED
Telaria, Inc.
TLRA
$14.4M 11.13%
7,799,997
-144,525
-2% -$265K
MRNS
3
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$3.13M 2.42%
615,350
– –
TBRA
4
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
– –
-23,806
Closed -$195K

Similar funds

A
Aetna Hartford, Connecticut $35.3M AUM 7.55% 1-Year Est. Return
TSP
Tappan Street Partners Chicago, Illinois $35.7M AUM 42.68% 1-Year Est. Return
SAC
SPQ Asia Capital Hong Kong $37.7M AUM 121.14% 1-Year Est. Return
MIGAR
Madison International Global Alpha Realty New York $25.9M AUM
CWM
Concert Wealth Management San Jose, California $24.7M AUM 14.91% 1-Year Est. Return
TCM
Trishield Capital Management New York $40.3M AUM
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
TAM
Target Asset Management Singapore $21.4M AUM 66.83% 1-Year Est. Return

Canaan Partners VII's Q2 2016 Portfolio in Review

As of Q2 2016, Canaan Partners VII held 4 positions worth $129M, down 47% from $243M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Canaan Partners VII's Q2 2016 filing shows 1 reduced and 1 closed positions. The largest sale was Telaria, Inc., an estimated $265K.

By sector, the portfolio is most concentrated in Financials at 86% of assets, down from 89% a quarter earlier, followed by Communication Services and Healthcare.

  • Canaan Partners VII's biggest Q2 2016 reduction was Telaria, Inc., cutting an estimated $265K.
  • Canaan Partners VII fully exited Tobira Therapeutics, Inc. Common Stock in Q2 2016, selling an estimated $195K.
  • Canaan Partners VII's ten largest holdings make up 100% of its $129M portfolio in Q2 2016.
  • Canaan Partners VII opened 0 new positions and closed 1 in Q2 2016.
  • Canaan Partners VII's portfolio value fell 47% quarter-over-quarter to $129M.

Based on Canaan Partners VII's 13F filing for Q2 2016, filed 6 Jul 2016.